Ourania Tatsis - Jun 26, 2024 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: Director
Signature: /s/ Andrew Ashe, as Attorney-in-Fact for Ourania Tatsis
Stock symbol: VERV
Transactions as of: Jun 26, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/28/2024, 07:45 AM
Previous filing: Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERV	Stock Option (right to buy)	Award	$0	+268K		$0.00	268K	Jun 26, 2024	Common Stock	268K	$5.02	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date of the option is the grant date. The shares of common stock underlying the option are scheduled to vest in equal monthly installments through June 26, 2027, subject to the Reporting Person's continued service as a director.

Content

This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date of the option is the grant date. The shares of common stock underlying the option are scheduled to vest in equal monthly installments through June 26, 2027, subject to the Reporting Person's continued service as a director.